Search

everythinglearnresearchcommunity

for

Search:↓

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Millet and wheat extracts may improve hair health and promote growth.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Hair follicles prevent NK cell attacks to avoid hair loss.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Skin-derived stem cells grow faster and are easier to obtain than hair follicle stem cells, but both can become various cell types.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Fisetin may help treat psoriasis and reduce skin inflammation.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Human foreskin does not show aging or reduced cell growth after radiation, and H2A.J is not a good marker for radiation-induced aging.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.